XML 24 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Restricted Stock
Total
Common Stock
Common Stock
Options and Restricted Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-in Capital
Restricted Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2020         95,600,000                
Balance at beginning of period at Dec. 31, 2020       $ 675.6 $ 1.0   $ 346.9     $ 360.2   $ (6.5) $ (26.0)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2020                         (1,400,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Common stock issued during period (in shares)         89,800,000 200,000              
Common stock issued during period $ 2,650.2       $ 0.9   2,649.3            
Acquisition of treasury stock (in shares)                         (1,400,000)
Acquisition of treasury stock (38.1)           0.4           $ (38.5)
Exercise of stock options (in shares)         600,000               900,000
Exercise of stock options 22.3           1.8           $ 20.5
Compensatory awards released from restriction (in shares)                         900,000
Compensatory awards released from restriction 0.0           (18.5)           $ 18.5
Share-based compensation 38.7   $ 33.0       38.7   $ 33.0        
Foreign currency translation equity adjustment (29.2)                     (29.2)  
Change in fair value of derivative instruments, net of tax 8.4                     8.4  
Net income (loss) $ 322.0                 322.0      
Balance at end of period (in shares) at Dec. 31, 2021         186,200,000                
Balance at end of period at Dec. 31, 2021   $ (44.7)   3,682.9 $ 1.9   3,051.6 $ (57.1)   682.2 $ 12.4 (27.3) $ (25.5)
Treasury stock, balance at end of period (in shares) at Dec. 31, 2021                         (1,000,000.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06                        
Acquisition of treasury stock (in shares)                         (1,600,000)
Acquisition of treasury stock $ (35.8)           0.3           $ (36.1)
Exercise of stock options (in shares)                         100,000
Exercise of stock options 0.7           (0.7)           $ 1.4
Compensatory awards released from restriction (in shares)                         1,200,000
Compensatory awards released from restriction 0.0           (29.0)           $ 29.0
Share-based compensation 47.0           47.0            
Foreign currency translation equity adjustment (44.7)                     (44.7)  
Change in fair value of derivative instruments, net of tax 10.5                     10.5  
Issuance of common stock related to convertible notes 0.5           0.5            
Capped call transaction related to convertible note conversion 0.0           0.1           (0.1)
Net income (loss) $ 157.9                 157.9      
Balance at end of period (in shares) at Dec. 31, 2022         186,200,000                
Balance at end of period at Dec. 31, 2022       3,774.3 $ 1.9   3,012.7     852.5   (61.5) $ (31.3)
Treasury stock, balance at end of period (in shares) at Dec. 31, 2022 (1,300,000)                       (1,300,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Acquisition of treasury stock (in shares)                         (3,300,000)
Acquisition of treasury stock $ (56.0)           0.0           $ (56.0)
Issuance of common stock (in shares) 800,000                        
Exercise of stock options (in shares) 300,000                       200,000
Exercise of stock options $ 4.2           (2.1)           $ 6.3
Compensatory awards released from restriction (in shares)                         1,100,000
Compensatory awards released from restriction 0.0           (24.6)           $ 24.6
Share-based compensation 46.7           46.7            
Foreign currency translation equity adjustment 12.8                     12.8  
Change in fair value of derivative instruments, net of tax 1.2                     1.2  
Net income (loss) $ 95.0                 95.0      
Balance at end of period (in shares) at Dec. 31, 2023         187,000,000.0                
Balance at end of period at Dec. 31, 2023       $ 3,878.2 $ 1.9   $ 3,032.7     $ 947.5   $ (47.5) $ (56.4)
Treasury stock, balance at end of period (in shares) at Dec. 31, 2023 (3,300,000)                       (3,300,000)